{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:08:26Z","timestamp":1783631306558,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rising cases of cognitive disorders, depression, and anxiety underscore the need for new treatments, given the limited effectiveness and side effects of current options. AdipoRon targets adiponectin receptors and shows promise for protecting the brain, reducing inflammation, and supporting metabolism. This review examines preclinical data to determine whether AdipoRon consistently improves mood and cognitive function and to identify the underlying neurobiological pathways. We conducted a comprehensive literature search using PubMed, Embase, Web of Science, and Scopus, with no time limit, up to August 30, 2025. The quality of the selected studies was evaluated using the Collaborative Approach to Meta-Analysis and Review of Animal Studies (CAMARADES) checklists and the SYRCLE risk of bias tool. The studies found that AdipoRon treatment significantly reduced immobility in the forced swim test and had a significant anxiolytic effect in the open field test, especially in chronic unpredictable mild stress models. It also improved recognition memory in the novel object recognition test in models of Alzheimer\u2019s and Parkinson\u2019s diseases. Additionally, AdipoRon increased the expression of synaptic proteins, such as synaptophysin and PSD-95, in rodent models of these diseases. It also modulated the production of inflammatory cytokines. This review establishes AdipoRon\u2019s capacity to resolve depressive, anxious, and cognitive deficits in rodent models. Because the meta-analyses were based on a limited number of studies and substantial heterogeneity was observed across studies, the findings should be interpreted with caution. However, further well-designed preclinical and clinical investigations are essential to confirm these findings.<\/jats:p>","DOI":"10.1186\/s13041-026-01323-0","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:48:18Z","timestamp":1781873298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic potential of AdipoRon in cognitive, depressive, and anxiety disorders: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Fatemeh Sadat","family":"Gheibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-4618","authenticated-orcid":false,"given":"Leila","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Kalejahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Dastgiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Reza","family":"Shafiee-Kandjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1985-1986","authenticated-orcid":false,"given":"Seyed Gholamreza","family":"Noorazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"issue":"3","key":"1323_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1192\/bjp.178.3.200","volume":"178","author":"M-P Austin","year":"2001","unstructured":"Austin M-P, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J psychiatry. 2001;178(3):200\u20136.","journal-title":"Br J psychiatry"},{"issue":"1","key":"1323_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-neuro-080317-062007","volume":"41","author":"SJ Bishop","year":"2018","unstructured":"Bishop SJ, Gagne C. Anxiety, depression, and decision making: a computational perspective. Annu Rev Neurosci. 2018;41(1):371\u201388.","journal-title":"Annu Rev Neurosci"},{"key":"1323_CR3","unstructured":"Beck AT, Alford BA, Depression. Causes and treatment: University of Pennsylvania; 2009."},{"issue":"4","key":"1323_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/jpm.12603","volume":"27","author":"M Crowe","year":"2020","unstructured":"Crowe M, Porter R, Douglas K, Inder M, Lacey C, Jordan J, et al. Patients\u2019 experiences of cognitive functioning in recurrent depression: a qualitative study. J Psychiatr Ment Health Nurs. 2020;27(4):321\u20139.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"5","key":"1323_CR5","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","volume":"23","author":"JH Stern","year":"2016","unstructured":"Stern JH, Rutkowski JM, Scherer PE. Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metabol. 2016;23(5):770\u201384.","journal-title":"Cell Metabol"},{"issue":"3","key":"1323_CR6","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/j.2040-4603.2018.tb00036.x","volume":"8","author":"H Fang","year":"2018","unstructured":"Fang H, Judd RL. Adiponectin regulation and function. Compr Physiol. 2018;8(3):1031\u201363.","journal-title":"Compr Physiol"},{"issue":"4","key":"1323_CR7","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/nu13041180","volume":"13","author":"K Khoramipour","year":"2021","unstructured":"Khoramipour K, Chamari K, Hekmatikar AA, Ziyaiyan A, Taherkhani S, Elguindy NM, et al. Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition. Nutrients. 2021;13(4):1180.","journal-title":"Nutrients"},{"issue":"10","key":"1323_CR8","doi-asserted-by":"publisher","first-page":"5669","DOI":"10.1038\/s41380-020-0701-0","volume":"26","author":"RC-L Ng","year":"2021","unstructured":"Ng RC-L, Jian M, Ma OK-F, Bunting M, Kwan JS-C, Zhou G-J, et al. Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer\u2019s disease mouse model. Mol Psychiatry. 2021;26(10):5669\u201389.","journal-title":"Mol Psychiatry"},{"issue":"7293","key":"1323_CR9","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/nature08991","volume":"464","author":"M Iwabu","year":"2010","unstructured":"Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, et al. Adiponectin and AdipoR1 regulate PGC-1\u03b1 and mitochondria by Ca2\u2009+\u2009and AMPK\/SIRT1. Nature. 2010;464(7293):1313\u20139.","journal-title":"Nature"},{"issue":"8","key":"1323_CR10","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s12035-020-01955-w","volume":"57","author":"L Wang","year":"2020","unstructured":"Wang L, Li N, Shi F-X, Xu W-Q, Cao Y, Lei Y, et al. Upregulation of AMPK ameliorates Alzheimer\u2019s disease-like tau pathology and memory impairment. Mol Neurobiol. 2020;57(8):3349\u201361.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"1323_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11010-017-3064-3","volume":"435","author":"R Velagapudi","year":"2017","unstructured":"Velagapudi R, El-Bakoush A, Lepiarz I, Ogunrinade F, Olajide OA. AMPK and SIRT1 activation contribute to inhibition of neuroinflammation by thymoquinone in BV2 microglia. Mol Cell Biochem. 2017;435(1):149\u201362.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1323_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41398-018-0210-y","volume":"8","author":"S Nicolas","year":"2018","unstructured":"Nicolas S, Debayle D, B\u00e9chade C, Maroteaux L, Gay A-S, Bayer P, et al. Adiporon, an adiponectin receptor agonist acts as an antidepressant and metabolic regulator in a mouse model of depression. Translational Psychiatry. 2018;8(1):159.","journal-title":"Translational Psychiatry"},{"key":"1323_CR13","doi-asserted-by":"publisher","first-page":"105876","DOI":"10.1016\/j.nbd.2022.105876","volume":"174","author":"M Khandelwal","year":"2022","unstructured":"Khandelwal M, Manglani K, Upadhyay P, Azad M, Gupta S. AdipoRon induces AMPK activation and ameliorates Alzheimer\u2019s like pathologies and associated cognitive impairment in APP\/PS1 mice. Neurobiol Dis. 2022;174:105876.","journal-title":"Neurobiol Dis"},{"issue":"17","key":"1323_CR14","doi-asserted-by":"publisher","first-page":"6419","DOI":"10.3390\/ijms21176419","volume":"21","author":"JY Kim","year":"2020","unstructured":"Kim JY, Barua S, Jeong YJ, Lee JE, Adiponectin. The potential regulator and therapeutic target of obesity and Alzheimer\u2019s disease. Int J Mol Sci. 2020;21(17):6419.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1323_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/ijms26020484","volume":"26","author":"SM de Barbalho","year":"2025","unstructured":"Barbalho SM, Laurindo LF, de Oliveira Zanuso B, da Silva RMS, Gallerani Caglioni L, et al. Nunes Junqueira de Moraes VBF. AdipoRon\u2019s impact on Alzheimer\u2019s disease: a systematic review and meta-analysis. Int J Mol Sci. 2025;26(2):484.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1323_CR16","doi-asserted-by":"publisher","first-page":"100166","DOI":"10.1016\/j.jnha.2024.100166","volume":"28","author":"L Sindzingre","year":"2024","unstructured":"Sindzingre L, Bouaziz-Amar E, Mouton-Liger F, Cognat E, Dumurgier J, Vrillon A, et al. The role of adiponectin in Alzheimer\u2019s disease: a translational review. J Nutr health aging. 2024;28(3):100166.","journal-title":"J Nutr health aging"},{"issue":"8","key":"1323_CR17","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.3390\/biomedicines13081867","volume":"13","author":"LF Laurindo","year":"2025","unstructured":"Laurindo LF, Dogani Rodrigues V, Haber Mellen R, Haber RSA, Valenti VE, Fornari Laurindo L, et al. AdipoRon as a Novel Therapeutic Agent for Depression: A Comprehensive Review of Preclinical Evidence. Biomedicines. 2025;13(8):1867.","journal-title":"Biomedicines"},{"issue":"4","key":"1323_CR18","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.3390\/ijms22042068","volume":"22","author":"TH Lee","year":"2021","unstructured":"Lee TH, Christie BR, van Praag H, Lin K, Siu PM-F, Xu A, et al. AdipoRon treatment induces a dose-dependent response in adult hippocampal neurogenesis. Int J Mol Sci. 2021;22(4):2068.","journal-title":"Int J Mol Sci"},{"key":"1323_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3389\/fphar.2019.00597","volume":"10","author":"B Liu","year":"2019","unstructured":"Liu B, Liu J, Wang J, Sun F, Jiang S, Hu F, et al. Adiponectin protects against cerebral ischemic injury through AdipoR1\/AMPK pathways. Front Pharmacol. 2019;10:597.","journal-title":"Front Pharmacol"},{"issue":"11","key":"1323_CR20","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s11064-024-04223-8","volume":"49","author":"N Azizifar","year":"2024","unstructured":"Azizifar N, Mohaddes G, Keyhanmanesh R, Athari SZ, Alimohammadi S, Farajdokht F. Intranasal AdipoRon mitigated anxiety and depression-like behaviors in 6-OHDA-induced Parkinson\u2019s disease rat model: going beyond motor symptoms. Neurochem Res. 2024;49(11):3030\u201342.","journal-title":"Neurochem Res"},{"issue":"15","key":"1323_CR21","doi-asserted-by":"publisher","first-page":"e70770","DOI":"10.1111\/jcmm.70770","volume":"29","author":"B Malaei","year":"2025","unstructured":"Malaei B, Farajdokht F, Mohaddes G, Mansouri B, Hamidi N, Alipour MR. AdipoRon mitigates anxiety and depression symptoms in chronic sleep-restricted mice via modulation of neuroinflammatory responses. J Cell Mol Med. 2025;29(15):e70770.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"1323_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/biomedicines11020249","volume":"11","author":"DA Formolo","year":"2023","unstructured":"Formolo DA, Lee TH, Yu J, Lin K, Chen G, Kranz GS, et al. Increasing adiponectin signaling by sub-chronic AdipoRon treatment elicits antidepressant-and anxiolytic-like effects independent of changes in hippocampal plasticity. Biomedicines. 2023;11(2):249.","journal-title":"Biomedicines"},{"issue":"9","key":"1323_CR23","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1007\/s12035-021-02441-7","volume":"58","author":"TH Lee","year":"2021","unstructured":"Lee TH, Ahadullah, Christie BR, Lin K, Siu PM-f, Zhang L, et al. Chronic AdipoRon treatment mimics the effects of physical exercise on restoring hippocampal neuroplasticity in diabetic mice. Mol Neurobiol. 2021;58(9):4666\u201381.","journal-title":"Mol Neurobiol"},{"key":"1323_CR24","doi-asserted-by":"publisher","first-page":"113249","DOI":"10.1016\/j.expneurol.2020.113249","volume":"327","author":"B Liu","year":"2020","unstructured":"Liu B, Liu J, Wang J-g, Liu C-l. Yan H-j. AdipoRon improves cognitive dysfunction of Alzheimer\u2019s disease and rescues impaired neural stem cell proliferation through AdipoR1\/AMPK pathway. Exp Neurol. 2020;327:113249.","journal-title":"Exp Neurol"},{"key":"1323_CR25","doi-asserted-by":"publisher","first-page":"111308","DOI":"10.1016\/j.brainresbull.2025.111308","volume":"224","author":"W Zhao","year":"2025","unstructured":"Zhao W, Li Y, Zhou Y, Zhao J, Lu Y, Xu Z. AdipoRon attenuates depression-like behavior in T2DM mice via inhibiting inflammation and regulating autophagy. Brain Res Bull. 2025;224:111308.","journal-title":"Brain Res Bull"},{"key":"1323_CR26","doi-asserted-by":"publisher","first-page":"113011","DOI":"10.1016\/j.intimp.2024.113011","volume":"141","author":"Y Liu","year":"2024","unstructured":"Liu Y, Fu X, Sun J, Cui R, Yang W. AdipoRon exerts an antidepressant effect by inhibiting NLRP3 inflammasome activation in microglia via promoting mitophagy. Int Immunopharmacol. 2024;141:113011.","journal-title":"Int Immunopharmacol"},{"key":"1323_CR27","doi-asserted-by":"publisher","first-page":"115174","DOI":"10.1016\/j.bbr.2024.115174","volume":"472","author":"G Bai","year":"2024","unstructured":"Bai G, Ling J, Lu J, Fang M, Yu S. Adiponectin receptor agonist AdipoRon alleviates memory impairment in the hippocampus of septic mice. Behav Brain Res. 2024;472:115174.","journal-title":"Behav Brain Res"},{"issue":"8","key":"1323_CR28","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s11064-024-04162-4","volume":"49","author":"W Zhao","year":"2024","unstructured":"Zhao W, Zhang W, Hu Y, Zhou Y, Zhao J, Li Y, et al. AdipoRon ameliorates synaptic dysfunction and inhibits tau hyperphosphorylation through the AdipoR\/AMPK\/mTOR pathway in T2DM mice. Neurochem Res. 2024;49(8):2075\u201386.","journal-title":"Neurochem Res"},{"issue":"6","key":"1323_CR29","doi-asserted-by":"publisher","first-page":"e13387","DOI":"10.1111\/acel.13387","volume":"20","author":"J You","year":"2021","unstructured":"You J, Sun L, Wang J, Sun F, Wang W, Wang D, et al. Role of Adiponectin-Notch pathway in cognitive dysfunction associated with depression and in the therapeutic effect of physical exercise. Aging Cell. 2021;20(6):e13387.","journal-title":"Aging Cell"},{"key":"1323_CR30","doi-asserted-by":"publisher","first-page":"110180","DOI":"10.1016\/j.neuropharm.2024.110180","volume":"262","author":"S Alimohammadi","year":"2025","unstructured":"Alimohammadi S, Mohaddes G, Keyhanmanesh R, Athari SZ, Azizifar N, Farajdokht F. Intranasal AdipoRon mitigates motor and cognitive deficits in hemiparkinsonian rats through neuroprotective mechanisms against oxidative stress and synaptic dysfunction. Neuropharmacology. 2025;262:110180.","journal-title":"Neuropharmacology"},{"key":"1323_CR31","doi-asserted-by":"publisher","first-page":"114355","DOI":"10.1016\/j.expneurol.2023.114355","volume":"363","author":"C Wang","year":"2023","unstructured":"Wang C, Chang Y, Zhu J, Wu Y, Jiang X, Zheng S, et al. AdipoRon mitigates tau pathology and restores mitochondrial dynamics via AMPK-related pathway in a mouse model of Alzheimer\u2019s disease. Exp Neurol. 2023;363:114355.","journal-title":"Exp Neurol"},{"issue":"17","key":"1323_CR32","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1111\/bph.16400","volume":"181","author":"F Sun","year":"2024","unstructured":"Sun F, Wang J, Meng L, Zhou Z, Xu Y, Yang M, et al. AdipoRon promotes amyloid-\u03b2 clearance through enhancing autophagy via nuclear GAPDH\u2010induced sirtuin 1 activation in Alzheimer\u2019s disease. Br J Pharmacol. 2024;181(17):3039\u201363.","journal-title":"Br J Pharmacol"},{"key":"1323_CR33","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/NDT.S367839","volume":"18","author":"S Liang","year":"2022","unstructured":"Liang S, Wu Y, Hanxiaoran L, Greenshaw AJ, Li T. Anhedonia in depression and schizophrenia: brain reward and aversion circuits. Neuropsychiatr Dis Treat. 2022;18:1385.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"1","key":"1323_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12974-022-02492-0","volume":"19","author":"H Wang","year":"2022","unstructured":"Wang H, He Y, Sun Z, Ren S, Liu M, Wang G, et al. Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression. J Neuroinflamm. 2022;19(1):132.","journal-title":"J Neuroinflamm"},{"key":"1323_CR35","doi-asserted-by":"publisher","first-page":"630380","DOI":"10.3389\/fimmu.2021.630380","volume":"12","author":"H-C Lin","year":"2021","unstructured":"Lin H-C, Chen Y-J, Wei Y-H, Lin H-A, Chen C-C, Liu T-F, et al. Lactic acid fermentation is required for NLRP3 inflammasome activation. Front Immunol. 2021;12:630380.","journal-title":"Front Immunol"},{"issue":"9","key":"1323_CR36","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00011-023-01790-4","volume":"72","author":"Y-H Han","year":"2023","unstructured":"Han Y-H, Liu X-D, Jin M-H, Sun H-N, Kwon T. Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflamm Res. 2023;72(9):1839\u201359.","journal-title":"Inflamm Res"},{"issue":"8","key":"1323_CR37","doi-asserted-by":"publisher","first-page":"pyv006","DOI":"10.1093\/ijnp\/pyv006","volume":"18","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Liu L, Liu Y-Z, Shen X-L, Wu T-Y, Zhang T, et al. NLRP3 inflammasome mediates chronic mild stress-induced depression in mice via neuroinflammation. Int J Neuropsychopharmacol. 2015;18(8):pyv006.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1323_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","volume":"36","author":"E Alcocer-G\u00f3mez","year":"2014","unstructured":"Alcocer-G\u00f3mez E, De Miguel M, Casas-Barquero N, N\u00fa\u00f1ez-Vasco J, S\u00e1nchez-Alcazar JA, Fern\u00e1ndez-Rodr\u00edguez A, et al. NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder. Brain Behav Immun. 2014;36:111\u20137.","journal-title":"Brain Behav Immun"},{"key":"1323_CR39","doi-asserted-by":"publisher","unstructured":"Li Y, Han S, Xie T, Song K, Zeng W, Wang H et al. AdipoRon ameliorates anxiety-and depression-like behaviors in chronic restraint-stressed mice via AMPK-PPAR\u03b1-BDNF-TrkB signaling. Eur J Pharmacol. 2025;178468. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178468.","DOI":"10.1016\/j.ejphar.2025.178468"},{"key":"1323_CR40","doi-asserted-by":"publisher","first-page":"472800","DOI":"10.3389\/fncel.2019.00363","volume":"13","author":"M Miranda","year":"2019","unstructured":"Miranda M, Morici JF, Zanoni MB, Bekinschtein P. Brain-derived neurotrophic factor: a key molecule for memory in the healthy and the pathological brain. Front Cell Neurosci. 2019;13:472800.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1323_CR41","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/ijms21031170","volume":"21","author":"E Palasz","year":"2020","unstructured":"Palasz E, Wysocka A, Gasiorowska A, Chalimoniuk M, Niewiadomski W, Niewiadomska G. BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int J Mol Sci. 2020;21(3):1170.","journal-title":"Int J Mol Sci"},{"key":"1323_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.brainres.2018.10.006","volume":"1704","author":"F Rahmani","year":"2019","unstructured":"Rahmani F, Saghazadeh A, Rahmani M, Teixeira AL, Rezaei N, Aghamollaii V, et al. Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: a systematic review and meta-analysis. Brain Res. 2019;1704:127\u201336.","journal-title":"Brain Res"},{"issue":"3","key":"1323_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","volume":"122","author":"CY Shao","year":"2011","unstructured":"Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A\u03b2 and tau pathology in transgenic mouse models of Alzheimer\u2019s disease. Acta Neuropathol. 2011;122(3):285\u201392.","journal-title":"Acta Neuropathol"},{"key":"1323_CR44","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fncel.2020.00082","volume":"14","author":"T Yang","year":"2020","unstructured":"Yang T, Nie Z, Shu H, Kuang Y, Chen X, Cheng J, et al. The role of BDNF on neural plasticity in depression. Front Cell Neurosci. 2020;14:82.","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1323_CR45","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.neuroscience.2010.04.023","volume":"168","author":"S Brummelte","year":"2010","unstructured":"Brummelte S, Galea LA. Chronic high corticosterone reduces neurogenesis in the dentate gyrus of adult male and female rats. Neuroscience. 2010;168(3):680\u201390.","journal-title":"Neuroscience"},{"issue":"3","key":"1323_CR46","doi-asserted-by":"publisher","first-page":"e70447","DOI":"10.1111\/acel.70447","volume":"25","author":"HH Guo","year":"2026","unstructured":"Guo HH, Ou HN, Yu JS, Luo ZR, Yau SY, Tsang HW. The Adiponectin-PP2A Pathway Confers Cognitive Benefits of Physical Exercise Against Chronic Stress-Induced Tau Hyperphosphorylation in the Hippocampus. Aging Cell. 2026;25(3):e70447.","journal-title":"Aging Cell"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-026-01323-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01323-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T08:03:42Z","timestamp":1782461022000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13041-026-01323-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1323"],"URL":"https:\/\/doi.org\/10.1186\/s13041-026-01323-0","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Tabriz University of Medical Sciences, IRAN. (Ethics No. IR.TBZMED.VCR.REC.1404.115)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}